Open
SectorHealthcare
4.68 5.88
24h
Min
4.26
Max
4.8
Income | 94M -22M |
---|---|
Sales | -51M 17M |
EPS | -1.05 |
Profit margin | -131.435 |
Employees | 131 |
EBITDA | -20M |
Recommendations | Buy |
---|---|
12 Months Forecast | +204.44% upside |
Next Earnings | 5 maj 2025 |
---|
Market Cap | -234M 122M |
---|---|
Previous open | -1.2 |
Previous close | 4.68 |
By Acuity
50%
50%
173 / 386 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 14.4 USD 204.44%
High 21 USD
Low 5 USD
Based on 5 Wall Street analysts offering 12 month price targets forENANTA PHARMACEUTICALS INC - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$